VIVO - Meridian Bioscience Inc.
Close
33.97
0 0%
Share volume: 0
Last Updated: Mon 30 Jan 2023 10:00:00 PM CET
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$33.97
0.00
0.00%
View ratios
| Fiscal Date | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | |
| Report Date | 2022-02-04 | 2022-05-06 | 2022-08-05 | 2022-11-22 | |
| Cash flow financing | -11.087 M | -24.383 M | 1.639 M | -472.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | 35.555 M | 30.417 M | 14.402 M | 1.987 M | |
| Net income | 15.340 M | 28.752 M | -7.338 M | 5.705 M | |
| Depreciation | 4.183 M | 4.152 M | 4.107 M | 4.069 M | |
| Changes in inventories | 74.198 M | 70.926 M | 70.105 M | 67.814 M | |
| Changes in receivables | 44.300 M | 59.218 M | 44.911 M | 47.235 M | |
| Investing Cashflow | -1.708 M | -1.471 M | -5.709 M | -2.227 M | |
| Net Borrowings | -35.155 M | -62.416 M | -72.453 M | -70.548 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -1.708 M | -1.471 M | -1.959 M | -3.477 M | |
| Cash Change | 72.729 M | 76.487 M | 83.487 M | 81.453 M |